Overcoming the barriers to the diagnosis of dementia

Postgraduate Medicine

Volumn 122, Issue 4, 2010, Pages 105-111

  Alagiakrishnan, Kannayiram ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dementia; Mild cognitive impairment; Mini Cog; MMSE; MoCA

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; GENERAL PRACTITIONER ASSESSMENT OF COGNITION; GOLD STANDARD; HUMAN; MEDICAL HISTORY; MENTAL HEALTH; MINI COG; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; SCREENING TEST; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; REVIEW;

COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC IMAGING; HUMANS; NEUROPSYCHOLOGICAL TESTS; PHYSICAL EXAMINATION;

EID: 77956632567     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.07.2178     Document Type: Article

References (44)

1. Boustani M, Peterson B, Hanson L, Harris R, Lohr KN; U.S. Preventive Services Task Force. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138(11):927-937.
2. Nobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 suppl):S4-S9.
3. Cummings H. Alzheimer's disease. N Engl J Med. 2004;351(1): 56-67.
4. Prince M. Dementia in developing countries. A consensus statement from the 10/66 Dementia Research Group. Int J Geriatr Psychiatry. 2000;15(1):14-20.
5. Ferri CP, Prince M, Brayne C, et al; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112-2117.
6. Xie J, Brayne C, Matthews FE; Medical Research Council Cognitive Function and Ageing Study collaborators. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ. 2008;336(7638):258-262.
7. Barclay LL, Zencov A, Blass JP, Sansone J. Survival in Alzheimer's disease and vascular dementias. Neurology. 1985;35(6):834-840.
8. Sternberg SA, Wolfson C, Baumgarten M. Undetected dementia in community-dwelling older people: The Canadian study of Health and Aging. J Am Geriatr Soc. 2000;48(11):1430-1434.
9. Walsh EG, Wu B, Mitchell JB, Berkmann LF. Cognitive function and acute care utilization. J Gerontol B Psychol Sci Soc Sci. 2003;58(1): S38-S49.
10. Löppönen M, Räihä Isoaho R, Vahlberg T, Kivelä SL. Diagnosing cognitive impairment and dementia in primary health care-a more active approach is needed. Age Ageing. 2003;32(6):606-612.
11. Knopman D, Donohue JA, Gutterman EM. Patterns of care in the early stages of Alzheimer's disease: impediments to timely diagnosis. J Am Geriatr Soc. 2000;48(3):300-304.
12. Callahan CM, Hendric HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med. 1995;122(6):422-429.
13. Boise L, Neal MB, Kaye J. Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol. 2004;59(6):M621-M626.
14. Ganguli M, Rodriguez E, Mulsant B, et al. Detection and management of cognitive impairment in primary care: the Steel Valley Seniors Survey. J Am Geriatr Soc. 2004;52(10):1668-1675.
15. Woods RT, Moniz-Cook E, Iliffe S, et al; INTERDEM (Early Detection and Intervention in Dementia) Group. Dementia: issues in early recognition and intervention in primary care. J R Soc Med. 2003;96(7): 320-324.
16. Barrett JJ, Haley WE, Harrell LE, Powers RE. Knowledge about Alzheimer disease among primary care physicians, psychologists, nurses and social workers. Alzheimer Dis Assoc Disord. 1997;11(2):99-106.
17. Harwood DM, Hope T, Jacoby R. Cognitive impairment in medical inpatients. II: do physicians miss cognitive impairment? Age Ageing. 1997;26(1):37-39.
18. Alagiakrishnan K, Marrie T, Rolfson D, et al. Gaps in patient care practices to prevent hospital-acquired delirium. Can Family Physician. 2009;55(10):e41-e46.
19. Folstein MF, Folstein SE, McHugh PR. "Mini-mental State. " A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
20. Molloy DW, Alemayehu E, Roberts R. Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. Am J Psychiatry. 1991;148(10):102-105.
21. Molloy DW, Standish TI. Mental status and neuropsychological assessment. A guide to the standardized Mini-mental state Examination. Int Psychogeriatr. 1997;9(suppl 1):87-94.
22. Costa PT Jr, Williams TF, Somerfield M, et al. Early identification of Alzheimer's disease and Related Dementias. Clinical Practice Guideline. Quick Reference Guide for Clinicians No. 19. Rockville, MD: US Dept of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR publication No. 97-0703. November 1996.
23. Swain DG, O'Brien AG, Nightingale PG. Cognitive assessment in elderly patients admitted to hospital: the relationship between the Abbreviated Mental Test and the Mini-Mental State Examination. Clin Rehabil. 1999:13(6):503-508.
24. Borson S, Scalan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive 'vital sign' measure for dementia screening in multi-lingual elderly. Int J Ger Psychiatry. 2000;15(11):1021-1027.
25. Brodaty H, Pond D, Kemp NM, et al. THE GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50(3):530-534.
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
27. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
28. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3): 179-186.
29. Teresi JA, Cross PS, Golden RR. Some applications of latent trait analysis to the measurement of ADL. J Georontol. 1989;44(5):S196-S204.
30. Nasreddine ZS, Phillips NA, Bédrian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
31. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194.
32. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985-1992.
33. Alagiakrishnan K. Treating vascular risk factors and preventing Alzheimer's. Res Pract Alzheimers Dis. 2007;12:59-63.
34. Alagiakrishnan K, McCracken P, Feldman H. Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline? Postgrad Med J. 2006;82(964):101-105.
35. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts, therapeutic implications. JAMA. 2004;292(23):2901-2908.
36. Kalra S, Bergeron C, Lang AE. Lewy body disease and dementia. Arch Intern Med. 1996;156(5):487-493.
37. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414.
38. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653-659.
39. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15-28.
40. Barton C, Sklenicka J, Sayegh P, Yaffe K. Contraindicated medication use among patients in a memory disorders clinic. Am J Geriatr Pharmacother. 2008;6(3):147-152.
41. Bech-Azeddine R, Waldemar G, Knudsen GM, et al. Idiopathic normal pressure hydrocephalus: evaluation and findings in a multidisciplinary memory clinic. Eur J Neurol. 2001;8(6):601-611.
42. Alagiakrishnan K, Sadowski CA. Managing non-Alzheimer's dementia with pharmacotherapy. Geriatr Aging. 2008;11(9):515-521.
43. Salloway S, Ferris S, Kluger A, et al; Donepezil 401 Study Group. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology. 2004;63(4):651-657.
44. Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2006; (1):CD001747.